QUTIRISH (RABIES) KASALLIGI: EPIDEMIOLOGIYA, PATOGENEZ, KLINIK BELGILARI, DIAGNOSTIKA, DAVOLASH VA PROFILAKTIKASI.
Ключевые слова:
qutirish, Lyssavirus, rabies virusi, postekspozitsion profilaktika, gidrofobiya, antirabik vaksinatsiya, zoonoz, neyroinfeksiya.Аннотация
Qutirish (rabies) — Lyssavirus avlodiga mansub neyrotrop virus chaqiradigan o‘tkir zoonoz infeksion kasallik bo‘lib, klinik belgilari yuzaga chiqqandan so‘ng deyarli 100% holatlarda o‘lim bilan yakunlanadi. Jahon sog‘liqni saqlash tashkiloti (WHO) ma’lumotlariga ko‘ra, har yili dunyo bo‘ylab qutirishdan 59 000 ga yaqin inson halok bo‘ladi va ularning 95%dan ortig‘i Osiyo va Afrika davlatlarida qayd etiladi. Mazkur obzor maqolaning maqsadi 2019–2025-yillarda nashr etilgan zamonaviy ilmiy manbalar asosida qutirish kasalligining epidemiologiyasi, etiologiyasi, patogenezi, klinik belgilari, diagnostikasi, davolash usullari va profilaktikasiga oid ma’lumotlarni tizimli tahlil qilishdan iborat. PubMed, Scopus, WHO va CDC ma’lumotlar bazalaridan foydalanib, 20 dan ortiq manba tahlilga kiritildi. Natijalarda qutirishning global tarqalishida Osiyo va Afrika mamlakatlarining yetakchi o‘rin egallashi, patogenezda virusning periferik nervlar orqali markaziy asab tizimiga retrograd transport mexanizmi, klinikada gidrofobiya va aerofobiyaning patognomonik belgilari hamda postekspozitsion profilaktikaning hal qiluvchi ahamiyati ko‘rsatib berildi. Xulosa o‘rnida, o‘z vaqtida amalga oshirilgan yaraga ishlov berish, antirabik vaksinatsiya va immunoglobulin yuborilishi kasallikning oldini olishning asosiy strategik yo‘nalishi ekanligi asoslab berildi.
Библиографические ссылки
1. World Health Organization. Rabies [fact sheet]. Geneva: World Health Organization; 2024 [cited 2025 Sep 10]. Available from: https://www.who.int/news-room/fact-sheets/detail/rabies
2. Gan H, Hou X, Wang Y, Xu G, Huang Z, Zhang T, et al. Global burden of rabies in 204 countries and territories, from 1990 to 2019: results from the Global Burden of Disease Study 2019. Int J Infect Dis. 2023;126:136–144.
3. World Health Organization, World Organisation for Animal Health, Food and Agriculture Organization. Zero by 30: the global strategic plan to end human deaths from dog-mediated rabies by 2030. Geneva: WHO; 2019.
4. World Health Organization. Rabies vaccines: WHO position paper, April 2018 – Recommendations. Vaccine. 2018;36(37):5500–5503.
5. Hampson K, Abela-Ridder B, Bharti O, Knopf L, Léchenne M, Mindekem R, et al. Zero human deaths from dog-mediated rabies by 2030: perspectives from quantitative and mathematical modelling. Gates Open Res. 2019;3:1564.
6. Pieracci EG, Pearson CM, Wallace RM, Blanton JD, Whitehouse ER, Ma X, et al. Vital Signs: trends in human rabies deaths and exposures – United States, 1938–2018. MMWR Morb Mortal Wkly Rep. 2019;68(23):524–528.
7. Ma X, Monroe BP, Wallace RM, Orciari LA, Gigante CM, Kirby JD, et al. Rabies surveillance in the United States during 2019. J Am Vet Med Assoc. 2021;258(11):1205–1220.
8. Aksenova OA, Movsesyants AA. Current state of the rabies problem in the Russian Federation and countries of the CIS. Epidemiology and Vaccinal Prevention. 2021;20(4):85–93.
9. Müller T, Freuling CM. Rabies in terrestrial wildlife and implications for human exposure: a continuous challenge in Europe. Rev Sci Tech OIE. 2020;39(2):395–411.
10. Banyard AC, Fooks AR. Rabies and other lyssavirus diseases. In: Granoff A, Webster RG, editors. Encyclopedia of Virology. 4th ed. Amsterdam: Elsevier; 2021. p. 738–747.
11. Fisher CR, Streicker DG, Schnell MJ. The spread and evolution of rabies virus: conquering new frontiers. Nat Rev Microbiol. 2018;16(4):241–255.
12. Fooks AR, Jackson AC, editors. Rabies: scientific basis of the disease and its management. 4th ed. Amsterdam: Academic Press; 2020.
13. Jackson AC. Rabies pathogenesis update. Rev Pan-Amaz Saúde. 2020;11: e202000373.
14. Hemachudha T, Wacharapluesadee S, Laothamatas J, Wilde H. Rabies. Curr Neurol Neurosci Rep. 2019;19(11):87.
15. World Health Organization. WHO Expert Consultation on Rabies: Third Report. WHO Technical Report Series 1012. Geneva: World Health Organization; 2018.
16. Dacheux L, Larrous F, Lavenir R, Lepelletier A, Faouzi A, Troupin C, et al. Dual combined real-time reverse transcription polymerase chain reaction assay for the diagnosis of lyssavirus infection. PLoS Negl Trop Dis. 2019;13(1):e0006935.
17. Kallel H, Mayence C, Houcke S, Mathien C, Mehdaoui H, Gaillet M, et al. Severe rabies presenting as encephalitis in French Guiana. Emerg Infect Dis. 2020;26(10):2496–2499.
18. Tarantola A, Ly S, In S, Ong S, Peng Y, Heng N, et al. Rabies post-exposure prophylaxis noncompletion after dog bites: estimating the unseen to meet the needs of the underserved. Am J Epidemiol. 2019;188(7):1340–1348.
19. Kansagra K, Parmar D, Mendiratta SK, Patel J, Joshi S, Sharma N, et al. A phase 3, randomized, open-label, noninferiority trial evaluating anti-rabies monoclonal antibody cocktail (TwinrabTM) against human rabies immunoglobulin (HRIG). Clin Infect Dis. 2021;73(9):e2722–e2728.
20. Centers for Disease Control and Prevention. Human rabies [Internet]. Atlanta (GA): CDC; 2024 [cited 2025 Sep 15]. Available from: https://www.cdc.gov/rabies/